Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

A new cancer vaccine is being created to analyse how pre-cancerous cells develop in order to target the disease before it ...

GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer prevention through vaccination. GSK is investing up to £50 ...

GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

Chip giant Nvidia ( NVDA) was more than 11% lower in the first hour of US trading. Industry peer ASML ( ASML) lost 8%, while Arm ( ARM ), Broadcom ( AVGO ), and Micron Technology ( MU) also got ...

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...